Universities need to make sure all faculty who want to work with the private sector have a chance to succeed, regardless of their gender or discipline. Miguel Tovar/University of Houston

The researchers had a hypothesis. Women faculty, they predicted, would be more successful than their male counterparts at earning private funding – from industry, from nonprofit groups, from charitable endowments. That was about relationships, after all, an area where the popular literature suggests women excel.

The numbers told a different story.

A review of faculty research funding conducted by the Center for ADVANCING Faculty Success at the University of Houston – funded by the National Science Foundation to help recruit and retain female faculty, and especially women of color, in STEM fields – found that women and men had similar success rates when competing for funding from federal agencies. With industry funding, however, the disparities were greater.

"It's about networking," says Christiane Spitzmueller, an industrial psychologist and managing director of the UH center. "Men do more of that. Women aren't primed as much for networking and self-marketing."

No one tracks the numbers nationally, and not all universities report a gender disparity. What is clear is that working with industry and nonprofit groups has drawn new attention in academia amid concerns about stagnant or dropping levels of federal research funding and increasing academic interest in finding solutions to some of society's thorniest problems. To take full advantage of the opportunities, universities need to make sure all faculty who want to work with the private sector have a chance to succeed, regardless of their gender or discipline.

Opportunity knocks

Industry needs these partnerships, too.

"Companies are realizing to be competitive, particularly in high-tech domains, they can't rely on only their internal resources," says Jeff Fortin, associate vice president for research and director of Research and Industrial Partnerships at Pennsylvania State University. "They have to look to universities and other external sources to fill that pipeline of innovation."

Some researchers are already fully engaged with industry. Others aren't interested.

Then there is the middle group. "They would like to engage more with companies," Fortin says. "They haven't done it much, and they need more help, explaining how the process works, the contracting."

His office – and those at other universities seeking to increase their interactions with the private sector – can help.

How to approach industry

Research administrators can help by developing policies for intellectual property, licensing and royalty issues that arise from academic-industry partnerships. Companies want to know how those issues will be handled upfront.

Ultimately, however, it's about the individual faculty member. And it requires persistence.

"The big thing is not to sell yourself short," says Rebecca Carrier, professor of chemical engineering at Northeastern University. "Maybe they're not going to be interested in precisely what you want to work on, but they might be interested in a variation of it."

Look for common goals. And prepare for a different type of relationship.

What to expect

Federal funding agencies generally require an annual report, with little or no interaction at other times. Not so with industry funding.

"When you're working on a project industry cares about, you may report in every six months, or conduct monthly or biweekly teleconferences. You may collaborate with their researchers. You may send your students to their site," says Elyse Rosenbaum, Melvin and Anne Louise Hassebrock Professor in Electrical and Computer Engineering at the University of Illinois-Urbana-Champaign. Rosenbaum also is director of the Center for Advanced Electronics through Machine Learning, a National Science Foundation Industry/University Cooperative Research Center.

Sometimes the work is about solving a specific industry problem, whether that's high workforce turnover or limiting methane emissions on oilfield drilling rigs. Sometimes, as Samira Ali, an assistant professor at the University of Houston Graduate College of Social Work, discovered with her first industry grant, the goal is more global.

Ali is directing one of three centers that are part of a $100 million, 10-year initiative from Gilead Sciences Inc. to address HIV/AIDS in the southern United States.

The payoff

Ali had never worked with industry funding, but the project was a good fit with her research interests. It also wasn't something the federal government would be likely to fund, making the partnership a pragmatic choice.

Another benefit? Carrier, who is director of the Advanced Drug Delivery Lab at Northeastern, says connecting with industry ensures she remains focused on real-world problems.

Working with the private sector is a constant reminder of the end goal – in Carrier's case, finding answers to questions about the mucosal barrier in the intestine, with an eye toward enhancing the absorption of medications and nutrients, as well as understanding links between the gut and overall health.

"It's important to stay in touch and in tune with people who are trying to make a product so that I know what I'm doing matters," she says.

The 411 in industry funding

What type of projects?

  • Short-term, often for a period of one year
  • Practical, focused on a specific product or project
  • Industry support for basic science is unusual but not unheard of

How is it different for government funding?

  • Generally less money, for a shorter period of time
  • Fewer restrictions but can require more flexibility
  • More contact, from biannual or monthly conference calls to sending researchers to work at the company, or having their researchers come to your lab
  • A new vocabulary. Terms understood to mean one thing by researchers and federal funding agencies may be used differently by industry

How to connect?

  • Network. Attend conferences that are important to the industry with which you'd like to work.
  • Educate yourself about the problems a particular industry needs to solve, and think about what solutions you may be able to offer
  • Be persistent and don't be afraid of rejection
  • Take advantage of personal connections – friends, neighbors and former classmates who work in industry may help you connect on specific projects

------

This article originally appeared on the University of Houston's The Big Idea.

Jeannie Kever works with the UH division of research as a senior media relations specialist.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston robotics co. closes series B after year of growth

money moves

Houston- and Boston-based Square Robot Inc. closed a series B round of funding last month.

The advanced submersible robotics company raised $13 million, according to Tracxn.com, and says it will put the funds toward international expansion.

"This Series B round, our largest to date, enables us to accelerate our growth plans and meet the surging global demand for our services,” David Lamont, CEO, said in a statement.

The company aims to establish a permanent presence in Europe and the Middle East and grow its delivery services to reach four more countries and one new continent in Q1 2025.

Additionally, Square Robot plans to release a new robot early next year. The robot is expected to be able to operate in extreme temperatures up to 60 C. The company will also introduce its first AI-enabled tools to improve data collection.

Square Robot launched its Houston office in 2019. Its autonomous, submersible robots are used for storage tank inspections and eliminate the need for humans to enter dangerous and toxic environments.

The company was one of the first group of finalists for the Houston Innovation Awards' Scaleup of the Year, which honors a Bayou City company that's seen impressive growth in 2024. Click here to read more about the company's growth.

------

This article originally ran on EnergyCapital.

Show me the money: Top Houston innovation grant and gift news of 2024

year in review

Editor's note: As the year comes to a close, InnovationMap is looking back at the year's top stories in Houston innovation. Money means a lot to startups and other innovative entities, and while startups are usually scouting venture capital investors, grants and donations are key too. These are the most-read news articles about grants and gifts — be sure to click through to read the full story.

Rice researchers secure $35M federal grant to advance medical device technology

Rice’s Biotech Launch Pad will lead the effort to commercialize the device. Photo courtesy Rice University

Rice University has secured part of a nearly $35 million federal grant aimed at commercializing a bioelectric implant for treatment of type 2 diabetes and obesity.

The federal Advanced Research Projects Agency for Health awarded the $34.9 million grant to Rice and several other universities.

Rice’s Biotech Launch Pad will lead the effort to commercialize the self-contained, implantable Rx On-site Generation Using Electronics (ROGUE) device. ROGUE houses cells that are engineered to produce type 2 diabetes and obesity therapies in response to patients’ needs. Continue reading.

Houston health care institutions receive $22M to attract top recruits

The grants, which are between $2 million to $6 million each, are earmarked for recruitment of prominent researchers. Photo via Getty Images

Houston’s Baylor College of Medicine has received a total of $12 million in grants from the Cancer Prevention & Research Institute of Texas to attract two prominent researchers.

The two grants, which are $6 million each, are earmarked for recruitment of Thomas Milner and Radek Skoda. The Cancer Prevention & Research Institute of Texas (CPRIT) announced the grants May 14.

Milner, an expert in photomedicine for surgery and diagnostics, is a professor of surgery and biomedical engineering at the Beckman Laser Institute & Medical Clinic at the University of California, Irvine and the university’s Chao Family Comprehensive Cancer Center. Continue reading.

New report ranks Houston top market for life sciences

Houston lands in the No. 7 spot for growth in the granting of degrees in biological and biomedical sciences. Photo by Natalie Harms/InnovationMap

Thanks in large part to producing hundreds of college-trained professionals, Houston’s life sciences industry ranks among the top U.S. markets for talent in 2024.

In a report published by commercial real estate services company CBRE, Houston lands in the No. 7 spot for growth in the granting of degrees in biological and biomedical sciences. From 2017 to 2022, Houston notched a growth rate of 32.4 percent in this category.

In 2022, the University of Houston led the higher education pack in the region, graduating 746 people with a bachelor’s degree or above in biological or biomedical sciences, according to the report. Continue reading.

Texas organization grants $68.5M to Houston institutions for recruitment, research

Several Houston organizations have received millions from the Cancer Prevention and Research Institute of Texas. Photo via tmc.edu

Three prominent institutions in Houston will be able to snag a trio of high-profile cancer researchers thanks to $12 million in new funding from the Cancer Prevention and Research Institute of Texas.

The biggest recruitment award — $6 million — went to the University of Texas MD Anderson Center to lure researcher Xiling Shen away from the Terasaki Institute for Biomedical Innovation in Los Angeles.

Shen is chief scientific officer at the nonprofit Terasaki Institute. His lab there studies precision medicine, including treatments for cancer, from a “systems biology perspective.” Continue reading.

Houston health care institution secures $100M for expansion, shares renderings

Baylor College of Medicine's Lillie and Roy Cullen Tower is set to open in 2026. Rendering courtesy of SLAM Architecture

Baylor College of Medicine has collected $100 million toward its $150 million fundraising goal for the college’s planned Lillie and Roy Cullen Tower.

The $100 million in gifts include:

  • A total of $30 million from The Cullen Foundation, The Cullen Trust for Health Care, and The Cullen Trust for Higher Education.
  • $12 million from the DeBakey Medical Foundation
  • $10 million from the Huffington Foundation
  • More than $45 million from members of Baylor’s Board of Trustees and other community donors, including the M.D. Anderson Foundation, the Albert and Margaret Alkek Foundation, and The Elkins Foundation.

“The Cullen Trust for Health Care is very honored to support this building along with The Cullen Foundation and The Cullen Trust for Higher Education,” Cullen Geiselman Muse, chair of The Cullen Trust for Health Care, says in a news release. “We cannot wait to see what new beginnings will come from inside the Lillie and Roy Cullen Tower.” Continue reading.

TMC launches cancer-focused partnership with Japan

global collaboration

Houston's Texas Medical Center announced the launch of its new TMC Japan BioBridge and Japan-Accelerator Cancer Therapeutics and Medical Devices, or JACT, this month.

The strategic partnership between Japan-based Mitsui Fudosan Co. Ltd. and the National Cancer Center will focus on advancing cancer treatments and providing a pathway for Japanese innovators to expand in the U.S. market. A delegation from TMC recently visited Tokyo, and William F. McKeon, president and CEO of TMC, signed the TMC Japan BioBridge Memorandum of Understanding with Takeshi Ozane, general manager of Mitsui Fudosan, and Hitoshi Nakagama, president of the National Cancer Center of Japan.

“The launch of TMC Japan BioBridge is a vital step forward in connecting two global leaders in healthcare innovation,” McKeon says in a statement. “Japan’s leadership has demonstrated an impressive commitment to advance medical cures and life sciences technologies and through this partnership, we are opening necessary doors for Japanese researchers and innovators to access the US market and collaborate with our TMC ecosystem. Together, we aim to accelerate critical breakthroughs to make a difference for patients all around the world.”

The new JACT will offer cancer-treatment companies a structured process to prepare for a U.S. expansion and will allow for meetings with pharmaceutical companies, hospital systems and investors and provide insights on U.S. regulatory approvals. It'll focus on three key areas, according to the statement:

  1. Milestone development and financial planning
  2. Clinical and regulatory expertise
  3. Strategic partnerships and market insights

“This TMC Japan BioBridge and JACT Program will enable us to promote the advancement of start-up companies aiming to commercialize innovative medical technologies originating in Japan into the U.S." Nakagama says in a statement. "We also hope this collaboration will not be limited to our (Japan Agency for Medical Research and Development)-supported project, but will lead to further cooperation between TMC, NCC, and other Japanese institutions in various fields.”

This is the sixth international strategic partnership for the TMC. It launched its first BioBridge, which focus on partnerships to support international healthcare companies preparing for U.S. expansion, with the Health Informatics Society of Australia in 2016. It also has BioBridge partnerships with the Netherlands, Ireland, Denmark and the United Kingdom.